BeStock  
Stocks › Biotechnology › REPL

Replimune REPL

US equityMarket cap rank #2747Biotechnology
$19.07 −$0.16 (-0.83%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $19.09 +0.10%
Open$18.84
Prev close$19.23
Day range$18.69 – $19.50
Volume1.96M
Market cap$1.81B
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

REPL at a glance

Replimune stock (REPL) sits at $19.07, down 0.83% today. The business is worth $1.81B in the market, good for #2747 of 3753 on our coverage list.

Over a full year the shares have ranged across $1.50 to $23.54, which puts the current price roughly 80% of the way up that band. Holders are ahead 107.3% over twelve months, and up 29.6% across the last three months.

On the chart it holds above both the 50-day ($15.34) and 200-day ($10.31) moving averages; RSI is 54, and the last 30 sessions moved at roughly 99% annualized volatility.

In the quarter ended Sep 2026 the company brought in $0.00 of revenue, and a net loss of $57.12M.

5 analysts follow the stock and the average call is "buy". The mean target, $24.00, sits 25.9% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$19.00 / $19.20
Average price today$19.00
Volume1.96MAvg (90d) 3.79M
Turnover$37.33M
Turnover rate3.00%of shares outstanding
Volume ratio0.95vs. recent average pace
Day amplitude4.21%
Market cap$1.81B
Float market cap$1.25B
Shares outstanding65.56M
EPS (TTM)-$3.38
P/B8.83
Book value / share$2.16
Net profit (TTM)-$320.43M
Net assets$204.77M
30-day volatility99.2%annualized
Avg daily range (ATR)7.12%of price, 14 days
Max drawdown (1y)-84.2%-18.1% from 1y peak

Quote as of Nov 21, 2026 9:10 am ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

B
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

B
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

C
Momentum

Trading closer to its 52-week high than most peers scores higher.

B
Wall Street

5 analysts, consensus Buy.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 36.3 · 2026-11-22 14:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation—
Growth—
Profitability1.9
Momentum91.5
Financial health32.7
Analyst view65.1

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$24.00+25.9% vs. current price
Consensus ratingBuy5 analysts covering
Morningstar fair value$37.38Price is below fair value

Wall Street’s average 12-month target is $24.00, 25.9% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $37.38, so shares trade 49.0% below that estimate. On earnings multiple, it sits in the 17th percentile of its own five-year valuation range (cheaper than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
-0.8%
1 week
-12.9%
1 month
+59.0%
3 months
+29.6%
6 months
+288.4%
Year to date
+96.2%
1 year
+107.3%
Day range
$18.69$19.50
52-week range
$1.50$23.54

Technical signals

Full technicals →
Trend readLeaning bullish

4 bullish · 3 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average-2.1%Bearish
Price vs 50-day average+24.3%Bullish
Price vs 200-day average+84.9%Bullish
50-day vs 200-day50d above 200dBullish
RSI (14)54.3Bullish
MACD (12,26,9)1.53Bearish
Bollinger band position47%Bearish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How REPL ranks on BeStock

Market value#2735 of 3734
Closeness to 52-week high#1396 of 3724
Dollar volume today#1628 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

REPL is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on REPL.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on REPL

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

REPL stock: common questions

How is Replimune stock doing today?

$19.07 is the latest print for REPL, a move of -0.83% against yesterday's close of $19.23. Today's low and high so far: $18.69 and $19.50.

How big is Replimune?

Equity value comes to $1.81B at the current price. By that measure it is number 2747 of the 3753 names in our coverage.

Where does REPL sit in its 52-week range?

The year's floor is $1.50 and the ceiling $23.54. Shares are 19.0% away from that ceiling.

Does REPL send cash back through a dividend?

Our data shows no dividend paid by Replimune over the trailing twelve months.

Do Wall Street analysts like REPL?

Of 5 analysts, 100% say buy, 0% hold and 0% sell. Price targets average $24.00, with the most cautious at $19.00 and the most optimistic at $31.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on REPL.

Sign in to join the discussion.

Scroll to Top